Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0002012383-25-000417
Filing Date
2025-02-03
Accepted
2025-02-03 17:57:03
Documents
3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5911
2 PowerOfAttorney.txt EX-24 2753
3 Item_7.txt EX-99 414
  Complete submission text file 0002012383-25-000417.txt   10955
Mailing Address 2340-2348 WALSH AVENUE, SUITE 2344 SANTA CLARA CA 95051
Business Address 2340-2348 WALSH AVENUE, SUITE 2344 SANTA CLARA CA 95051 408-627-4557
Semler Scientific, Inc. (Subject) CIK: 0001554859 (see all company filings)

EIN.: 261367393 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-88028 | Film No.: 25584070
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address 50 HUDSON YARDS NEW YORK NY 10001
Business Address 50 HUDSON YARDS NEW YORK NY 10001 (212) 810-5800
BlackRock, Inc. (Filed by) CIK: 0002012383 (see all company filings)

EIN.: 991116001 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A
SIC: 6211 Security Brokers, Dealers & Flotation Companies
(CF Office: 02 Finance)